Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity

Journal of Autoimmunity

Volumn 9, Issue 4, 1996, Pages 509-516

  Zhang, Hongwei ^a   Kaur, Indreshpal ^a   Niesel, David W ^a   Seetharamaiah, Gattadahalli S ^a   Peterson, Johnny W ^a   Justement, Louis B ^a   Prabhakar, Bellur S ^a   Klimpel, Gary R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Antibody; Autoimmunity; Bacteria; Grave's disease; IL 6; Mitogen; Thyrotropin receptor; Yersinia

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; ETIOLOGY; FEMALE; GRAVES DISEASE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; YERSINIA ENTEROCOLITICA;

EID: 0030219469     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0068     Document Type: Article

References (44)

1. 1. Kidd A., Okita N., Row V.V., Volpe R. 1980. Immunologic aspects of Graves' and Hashimoto's diseases. Metabolism 29: 80-99
2. 2. Heyma P., Harrison L.C. 1984. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. J. Clin. Invest. 74: 1090-1097
3. 3. Smith B.R., Mclachlan S.M., Furmaniak J. 1988. Autoantibodies to the thyrotropin receptor. Endocrine Rev. 9: 106-121
4. 4. Ciampolillo A., Mirakian R., Schulz T., Vittoria M., Buscema M., Pujol-Borrell R., Bottazzo G.F. 1989. Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet 1: 1096-1099
5. 5. Islam M.N., Pepper B.M., Briones-Urbina R., Farid N.R. 1983. Biological activity of antithyrotropin and anti-idiotypic antibody. Eur. J. Immunol. 13: 57-63
6. 6. Oldstone M.B.A. 1987. Molecular mimicry and autoimmunity disease. Cell 50: 819-820
7. 7. Paliard X., West S.G., Lafferty J.A., Clements J.R., Kappler J.W., Marrack P., Kotzin B.L. 1991. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253: 325-329
8. 8. Tomer Y, Davies T.F. 1993. Infection, thyroid disease and autoimmunity. Endocrine Rev. 14: 107-120
9. 9. Bech K., Larsen J.H., Hansen J.M., Nerup J. 1974. Yersinia enterocolitica infection and thyroid disorder. Lancet 2: 951-952
10. 10. Weiss M., Rubinstein F., Bottone E.J., Shenkman L., Bank H. 1979. Yersinia enterocolitica antibodies in thyroid disorder. Isr. J. Med. Sci. 15: 553-555
11. 11. Shenkman L., Bottone E.J. 1976. Antibodies to Yersinia enterocolitica in thyroid disease. Ann. Intern. Med. 85: 735-739
12. 12. Weiss P., Ingbar S.H., Winblad S., Kasper D.L. 1983. Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science 219: 1331-1333
13. 13. Heyman P., Harrison L.C., Robins-Browne R. 1986. Thyrotropin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Clin. Exp. Immunol. 64: 249-254
14. 14. Shenkman L., Bottone E.J. 1981. The occurrence of antibodies to Yersinia enterocolitica. In Yersinia enterocolitica, ch. 13 E.J. Bottone (ed.); CRC Press, Boca Raton, Florida, Chapter 13, pp. 135-144
15. 15. Wenzel B.E., Heesemann J., Wenzel K.W, Scriba P.C. 1988. Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1: 56
16. 16. Franke T.F., Wenzel B.E. 1991. A molecular basis for antigen homologies of thyroid epithelial cells and plasmid-encoded proteins of Yersinia enterocolitica. Contributions to Microbiology & Immunology 12: 89-92
17. 17. Wenzel B.E., Heesemann J., Wenzel K.W., Scriba P.C. 1988. Patients with autoimmune thyroid diseases have antibodies to plasmid encoded proteins of enteropathogenic Yersinia. J. Endocrinol. Invest. 11: 139-140
18. 18. Luo G., Fan J.L., Seetharamaiah G.S., Desai R.K., Dallas J.S., Wagle N., Doan R., Niesel D.W., Klimpel G.R., Prabhakar B.S. 1993. Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J. Immunol. 151: 922-928
19. 19. Luo G., Seetharamaiah G.S., Niesel D.W., Zhang H., Peterson J.W, Prabhakar B.S., Klimpel G.R. 1994. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J. Immunol. 152: 2555-2561
20. 20. Westphal O., Jann K. 1965. In Methods in Carbohydrate Chemistry Whistler R.L. (ed.) 5th edn.; Academic Press, New York, pp. 83-92
21. 21. Ramarathinam L., Niesel D.W., Klimpel G.R. 1993. Ity influences the production of IFN-γ by murine splenocytes stimulated in vitro with Salmonella typhimurium. J. Immunol. 151: 3965-3972
22. 2+ mobilizing signals when expressed on differentiated B lineage cells. J. Immunol. 144: 3272-3280
23. 3H/HeJ spleen cells. J. Exp. Med. 144: 840-846
24. 24. Gallay P., Jongeneel C.V., Buras C., Burnier M., Baumgartner J.D., Glauser M.P., Heumann D. 1993. Short time exposure to LPS is sufficient to activate human monocytes. J. Immunol. 150: 5086-5093
25. 25. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73-76
26. 26. Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaida T., Yoshizaki K., Yamamura Y. 1981. T cell-replacing factor (TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J. Immunol. 127: 412-416
27. 27. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K.H., Kishimoto T. 1985. Purification to homogeneity and characterization of human B cell differentiation factor (BCDR or BSFp-2). Proc. Natl Acad. Sci. USA 82: 5490-5494
28. 28. Kishimoto T. 1989. The biology of IL-6. Blood 74: 1-10
29. 29. Van Snick J.A. 1990. IL-6. Ann. Rev. Immun. 8: 253-278
30. 30. Melchers F., Braun V., Galanos C. 1975. The lipoprotein of the outer membrane of Escherichia coli. A B-lymphocyte mitogen. J. Exp. Med. 142: 473-482
31. 31. Bessler W.G., Ottenbreit B.P. 1977. Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. Biochem. Biophys. Res. Commun. 76: 239-246
32. 32. Vordermeier H.M., Bessler W.G. 1987. Polyclonal activation of murine B-lymphocyte in vitro by Salmonella typhimurium porins. Immunology 175: 245-251
33. 33. Vordermeier H.M., Stäb K., Bessler W.G. 1986. A defined fragment of bacterial protein I (Omp F) as a polyclonal B-cell activator. Infect. Immun. 51: 233-239
34. 34. Goodman G.W, Sultzer B.M. 1979. Characterization of the chemical and physical properties of a novel B-lymphocyte activator, endotoxin protein. Infect. Immun. 24: 685-696
35. 3H/Hej lymphocytes. J. Exp. Med. 144: 821-827
36. 36. Betz S., Morrison D.C. 1977. Chemical and biologic properties of a protein-rich fraction of bacterial lipopolysaccharides. J. Immunol. 119: 1475-1481
37. 3H/Hej spleen cells. J. Exp. Med. 144: 840-846
38. 38. Braun B. 1975. Covalent lipoprotein from the outer membrane of E. coli. Biochim. Biophys. Acta 415: 335-377
39. 39. Inouye M. 1975. Biosynthesis and assembly of the outer membrane proteins of E. coli. In Membrane Biogenesis Tzagology A. (ed.); Plenum Publishing Corp., New York, pp. 351-391
40. 40. Stuart P.M., Woodward J. 1992. Yersinia enterocolitica produces superantigenic activity. J. Immunol. 148: 225-233
41. 41. Miyoshi-Akiyama T., Imanishi K., Uchiyama T. 1993. Purification and partial characterization of a product from Yersinia pseudotuberculosis with ability to activate human T cells. Infect. Immunol. 61: 3922-3927
42. 42. Abe J., Takeda T., Watanabe Y., Nakao H., Kobayashi N., Leung D., Kohsaka T. 1993. Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol. 151: 4183-4188
43. 43. Tumang J.R., Posnett D.N., Cole B.C., Crow M.K., Friedman S.M. 1990. Helper T cell dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J. Exp. Med. 171: 2153-2158
44. 44. Mourad W., Scholl P., Diaz A., Geha R., Chatila T. 1989. The TSST-1 triggers B cell proliferation and differentiation via major histocompatibility complex unrestricted cognate T/B cell interaction. J. Exp. Med. 170: 2011-2022